SynbiasPharma/Gemini
About us

Synbias-Gemini Group

Innovating Highly Potent APIs for a Healthier Tomorrow

The Synbias-Gemini Group operates under the umbrella of Synbias Pharma AG, headquartered in Schaffhausen, Switzerland, which 100% shareholder of Gemini PharmChem Mannheim GmbH, our production facilities, a highly esteemed manufacturing and R&D site located in Mannheim, Germany.

Our primary specialization lies in developing and manufacturing highly potent Active Pharmaceutical Ingredients (APIs), primarily used in cancer therapies.

Our product portfolio includes Anthracyclines, Nucleosides, and Plant Alkaloids.

As the leading global API supplier of anthracycline antibiotics, we hold a 30-50% share of the world market. Annually, approximately 200 kilograms of our APIs, in quantities ranging from 100 grams to 15 kilograms, are shipped to customers in 21 countries across 5 continents. Our Quality System is meticulously designed to meet the stringent requirements of cGMP and is inspected by German authorities, Swissmedic, FDA, ANVISA and our customers.

Gemini PharmChem is recognized by our business partners as a competent, reliable, and efficient company, characterized by our innovative spirit and customized approach to service. Our leading position in niche markets is built on the expertise, dedication, and loyalty of our employees. We are capable of developing manufacturing processes for New Chemical Entities and supplying APIs for all phases of a drug’s life cycle, from initial clinical studies to commercial supply.

SynbiasPharma/Gemini
Synbias-Gemini Group © 2015 - 2024. All rights Reserved
Cookies
We Use Essential Cookies Only

Our website uses only essential cookies that are necessary for its proper functioning. We do not use cookies for tracking or advertising purposes. For more details, please refer to our Privacy policy.